A significant breakthrough in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently lost in various forms of malignancies, leading https://bookmarklinking.com/story342188/nanobodies-restore-the-p53-protein-the-potential-approach-for-malignant-management